rapid microbiology website
Click here for more details
NAVIGATE
HOME
News
Events/Meetings
Test Methods
Search
Newsletter
 
SEARCH NEWS
For microbes [a..z]:
A B C D E F G H I
J K L M N 0 P Q R
S T U V W X Y Z  

FIND
Suppliers
A..Z
by Sector Topic
by Country
Service Labs.
Find a Laboratory
Other
B2B
Links
 
THIS SITE
Add to site
News item
Event/Meeting
Supplier details
Service Lab.
About
Advertising
Content
Privacy
RSS/XML? what is RSS/XML?
News word search
 
SUBSCRIBE TO NEWS
Oxoid Ltd.
Contact: Val Kane
Email: val.kane@thermofisher.com
Tel : +[44] 1256 841144
Fax: +[44] 1256 463388
RSS feed about Oxoid Ltd.
Oxoid Ltd. logo
VISIT WEBSITE

New Medium for Pharmaceutical Media Fill Trials

Oxoid Cold Filterable TSB

Microbiology specialists, Oxoid Limited, have launched gamma-irradiated, Cold Filterable Tryptone Soya Broth (CM1065) - a highly nutritious general purpose medium which is ideal for microbiological Media Fill Trials (MFT) in the pharmaceutical industry.

Dehydrated Cold Filterable Tryptone Soya Broth (TSB) can be substituted for the powdered components that go into making aqueous drug products. After carrying out MFT, including the filter-sterilisation process, the medium is incubated for the recovery of contaminating bacteria, yeasts and moulds1. This provides an index of the level of microbiological contamination occurring in aseptic manufacture and can be used to identify problems in contamination control.

The components of Oxoid Cold Filterable TSB have been specially screened and selected to ensure a highly filterable solution. Each batch will have a known Vcap (minimum 2,800 litres/m2) tested using three different filter types (0.2mm pore size): PVDF, PES and nylon. This allows the maximum filterable volume to be calculated before starting a MFT.

Oxoid Cold Filterable TSB may also be used to test aseptic production processes for solid presentations by adding the medium as a sterile liquid downstream of processing a placebo.

Gamma-irradiation of the medium ensures that it is free from all yeasts, moulds and bacteria, including bacterial spores and mycoplasmas, prior to use.

The Oxoid Cold Filterable TSB formulation conforms to that stated for MFT in the European2, British3, US4 and Japanese5 Pharmacopoeias.


References:
1. Oxoid Manual 8th Edition, 1998, p2-208.
2. European Pharmacopoeia 4th Edition 2002.
3. British Pharmacopoeia 2003.
4. US pharmacopoeia 27 NF22 2004.
5. Japanese Pharmacopoeia XIV 2001.


Source: Oxoid Ltd.
Posted: May 28, 2004

 

Top |  Home |  Site Map |  News |  Find Laboratory |  Labs. by Country |  Events
©Copyright rapidmicrobiology.com